Table 1.
Characteristics | Number of cases | |
---|---|---|
Responses in | English | 18/28 * |
Spanish | 7/28 * | |
Portuguese | 3/28 * | |
Respondents were | Neurologists | 19/28 * |
Clinical geneticists | 4/28 * | |
Neuropediatricians | 1/28 * | |
Professionals related to molecular diagnoses | 3/28 * | |
Other | 1/28 * | |
Answers were about | Public services | 20/26 |
Private health services | 6/26 | |
Geographic origin | Argentina | 1/26 |
Bolivia | 1/26 | |
Brazil | 11/26 | |
Canada | 2/26 | |
Chile | 3/26 | |
Cuba | 1/26 | |
Mexico | 3/26 | |
USA | 2/26 | |
Uruguay | 1/26 | |
Peru | 1/26 | |
Answers about the total number of ataxic patients under current care | 25/26 | |
Answers about the total number of ataxic families under current care | 19/26 | |
Answers about specific diagnoses per subject in the last 20 years | 12/26 | |
Answers about specific diagnoses per family in the last 20 years | 10/26 |
Number of respondents. The other items comprised the number of sites